Results 31 to 40 of about 56,737 (220)

Pneumococcal pneumonia and the risk of stroke: a population-based follow-up study. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: To investigate the risk of developing stroke in patients hospitalized following a diagnosis of pneumococcal pneumonia. METHODS: The study cohorts comprised of patients hospitalized with a principal diagnosis of pneumococcal pneumonia (n ...
Li-Fu Chen   +5 more
doaj   +1 more source

No temporal association between influenza outbreaks and invasive pneumococcal infections [PDF]

open access: yes, 2008
Objective: To assess whether the influenza peak in populations precedes the annual peak for invasive pneumococcal infections (IPI) in winter.Design: Ecological study.
Arenz, Stephan   +3 more
core   +1 more source

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

open access: yes, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
French, N   +9 more
core   +4 more sources

Evaluation of epidemiological and clinical features of patients with pneumococcal and legionella pneumonia

open access: yesBiomedical and Biotechnology Research Journal, 2019
Background: Pneumonia is one of the major causes of morbidity, mortality, and hospitalization. It is developed by a variety of organisms including Streptococcus pneumoniae and Legionella spp.
Tina Rabooki   +4 more
doaj   +1 more source

The TRIP database showed most Acute Respiratory Infections questions were already addressed by Cochrane reviews [PDF]

open access: yes, 2019
OBJECTIVE: Cochrane systematic reviews require more methodological support from Cochrane Review Groups (CRGs) than is customary in journals, CRGs must prioritise reviews to conserve resources.
Brassey, Jon   +4 more
core   +1 more source

Burden of pneumococcal disease in children in Cuba before the introduction of a novel pneumococcal conjugate vaccine

open access: yesJournal of Global Health Reports, 2019
# Background The Cuban heptavalent conjugate pneumococcal vaccine will be introduced for children beginning in 2020. We estimated the burden of pneumococcal cases and deaths in children 1-59 months in 2015.
Nivaldo Linares-Pérez   +4 more
doaj   +1 more source

Mortality from infectious pneumonia in metal workers: a comparison with deaths from asthma in occupations exposed to respiratory sensitizers [PDF]

open access: yes, 2009
Introduction: national analyses of mortality in England and Wales have repeatedly shown excess deaths from pneumonia in welders. During 1979-1990 the excess was attributable largely to deaths from lobar pneumonia and pneumonias other than ...
Brown, Terry   +4 more
core   +1 more source

The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions. [PDF]

open access: yesPLoS ONE, 2012
Recent studies have shown that most of deaths in the 1918 influenza pandemic were caused by secondary bacterial infections, primarily pneumococcal pneumonia.
Yu-Wen Chien   +2 more
doaj   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

open access: yesAdvanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao   +16 more
wiley   +1 more source

MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia

open access: yesCells, 2023
Community-acquired pneumonia remains a major contributor to global communicable disease-mediated mortality. Neutrophils play a leading role in trying to contain bacterial lung infection, but they also drive detrimental pulmonary inflammation, when ...
Cengiz Goekeri   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy